Skip Ribbon Commands
Skip to main content


The Epidemiology, Modeling and Trial Designs Community is comprised of individuals from different Institutions worldwide and includes the following members:​​

Dr Frank ​Cobelens


Frank Cobelens is professor of Global Health at the University of Amsterdam, The Netherlands. His scientific interest is multidisciplinary approaches to problems on the interface of biomedical aspects of infectious diseases (notably tuberculosis), their socioeconomic context and public health policy, as well as in evaluation of control interventions. ​

Dr Richard White


Richard White is a Prof of Infectious Disease Modelling at LSHTM. His research focus is the mathematical and statistical modelling of the transmission and control of infectious diseases, particularly TB and HIV. He is Director of the TB Modelling and Analysis Consortium, and co-leads the LSHTM TB Modelling Group.


Dr Marcel Behr

Dr. Behr is a clinician-scientist with appointments of Full Professor in the Department of Medicine and Associate member in the departments of Epidemiology and Biostatistics as well as Microbiology and Immunology. He is the founding Director of the McGill International TB Centre and led it from 2012 to 2018. He is the Associate Program Leader of the Infectious Diseases and Immunity in Global Health Program at the Research Institute of the McGill University Health Centre since 2016 and in 2017 he became the co-Director the McGill Interdisciplinary Initiative in Infection and Immunity (McGill-i4). He is the interim director of McGill Infectious Diseases Division.

Dr. Behr trained at the University of Toronto, Queen’s, McGill and Stanford. His work has been recognized by election into the Canadian Academy of Health Sciences, the Royal Society of Canada, the American Society for Clinical Investigation and the American Academy of Microbiology. Dr. Behr’s lab uses bacterial genomic methodologies to study the epidemiology and pathogenesis of tuberculosis and other mycobacterial diseases.


Dr Gavin Churchyard

Prof Churchyard (MBBCh, MMED (Int Med), FCP (SA), FRCP (Edin), PhD) is a specialist physician, internationally renowned for his contributions in tuberculosis (TB) research. Prof Churchyard is the founder and Group Chief Executive Officer of the Aurum Institute, an independent, not for profit, proudly South African, public benefit organization that focuses on TB and HIV technical assistance, service delivery, and research. Prof Churchyard is an Honorary Professor at the University of Witwatersrand and University of Cape Town. Prof Churchyard is the Chair of the AIDS Clinical Trials Group (ACTG) Transformative Science Group for TB, Chair of the Cross-Network TB vaccine Working Group and a member of the ACTG New Chemical Entities Working Group. He has extensive clinical trials experience and has conducted numerous TB treatment, TB vaccine, TB preventive therapy, TB diagnostics and Host Directed Therapy for TB trials.


Dr Tom Evans

Dr Alberto Garcia-Basteiro

Dr Rebecca Harris

Dr Mark Hatherill

Dr Philip Hill

Dr Robin Mogg

Dr Matthew Quaife

Dr Alexander Schmidt

Dr Dereck Tait